Piccina Cintia has filed 6 insider transactions across 1 company since March 2024.
Most recent transaction: a grant/award of 1612032 shares of Adaptimmune Therapeutics PLC ($ADAPY) on February 20, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | A | Option to purchase Ordinary Shares | 1612032 | $0.00 | 1,612,032.0000 | 1,513,810,852 | 9999.99% | 0.11% |
| Feb. 20, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | A | Option to purchase Ordinary Shares | 1074696 | $0.00 | 1,074,696.0000 | 1,513,810,852 | 9999.99% | 0.07% |
| Jan. 15, 2025 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | S | American Depositary Shares representing Ordinary Shares | 12991 | $0.57 | 18,421.0000 | 1,513,810,852 | 41.36% | 0.00% |
| June 18, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | S | American Depositary Shares representing Ordinary Shares | 24531 | $0.93 | 38,293.0000 | 1,451,241,661 | 39.05% | 0.00% |
| March 18, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | A | Option to purchase Ordinary Shares | 5088864 | $0.00 | 5,088,864.0000 | 1,206,440,978 | 9999.99% | 0.42% |
| March 18, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Piccina Cintia | Chief Commercial Officer | A | Option to purchase Ordinary Shares | 1130832 | $0.00 | 1,130,832.0000 | 1,206,440,978 | 9999.99% | 0.09% |